8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)
Published . Updated .
Key takeaways
- 8-K - Mirum Pharmaceuticals filed an 8-K with the SEC on Nov 10 (a notice of a material company event).
- Exposed: MIRM
- Market reaction: MIRM −1.0% after three sessions (still updating)
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Mirum Pharmaceuticals filed an 8-K with the SEC on Nov 10 (a notice of a material company event).
Directly affected
- MIRM Mirum Pharmaceuticals
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MIRM | -6.49% | +0.47% | base | +1.46% | +1.71% | +0.28% | -1.02% |
| XLV | -2.31% | -1.80% | base | +0.27% | +0.29% | -0.10% | -0.27% |
| XBI | -1.25% | -5.41% | base | -1.18% | -0.41% | -3.64% | -5.19% |
| LLY | -0.21% | -3.19% | base | +1.42% | +1.80% | +1.26% | +1.01% |
| JNJ | -5.66% | -3.43% | base | -0.48% | -0.63% | +0.51% | +1.26% |
| PFE | +2.51% | +2.17% | base | +0.39% | +0.70% | -1.42% | -1.49% |
| MRK | -2.73% | -1.23% | base | -0.49% | -1.02% | -1.19% | -1.76% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-10 AccNo: 0001759425-26-000064 Size: 171 KB Item 8.01: Other Events
Source: sec-edgar
Mirum Pharmaceuticals (MIRM)
Those 3 earlier stories put Mirum Pharmaceuticals (MIRM) at an average move of +1.06% the next day. Largest gain +7.45%, largest drop -7.07%, from 3 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals (MIRM) | the next day | +1.06% | +7.45% | -7.07% | 3 |
| Mirum Pharmaceuticals (MIRM) | three days later | +0.58% | +6.94% | -6.96% | 3 |
The price since 10 Nov 2026: Mirum Pharmaceuticals (MIRM) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| JNJ | that day | -0.48% | final price |
| JNJ | the next day | -0.63% | final price |
| JNJ | two days later | +0.51% | final price |
| JNJ | three days later | +1.26% | still updating |
| JNJ | three days earlier | -3.43% | final price |
| JNJ | five days earlier | -5.66% | final price |
| LLY | that day | +1.42% | final price |
| LLY | the next day | +1.80% | final price |
| LLY | two days later | +1.26% | final price |
| LLY | three days later | +1.01% | still updating |
| LLY | three days earlier | -3.19% | final price |
| LLY | five days earlier | -0.21% | final price |
| Mirum Pharmaceuticals (MIRM) | that day | +1.46% | final price |
| Mirum Pharmaceuticals (MIRM) | the next day | +1.71% | final price |
| Mirum Pharmaceuticals (MIRM) | two days later | +0.28% | final price |
| Mirum Pharmaceuticals (MIRM) | three days later | -1.02% | still updating |
| Mirum Pharmaceuticals (MIRM) | three days earlier | +0.47% | final price |
| Mirum Pharmaceuticals (MIRM) | five days earlier | -6.49% | final price |
| MRK | that day | -0.49% | final price |
| MRK | the next day | -1.02% | final price |
| MRK | two days later | -1.19% | final price |
| MRK | three days later | -1.76% | still updating |
| MRK | three days earlier | -1.23% | final price |
| MRK | five days earlier | -2.73% | final price |
| PFE | that day | +0.39% | final price |
| PFE | the next day | +0.70% | final price |
| PFE | two days later | -1.42% | final price |
| PFE | three days later | -1.49% | still updating |
| PFE | three days earlier | +2.17% | final price |
| PFE | five days earlier | +2.51% | final price |
| XBI | that day | -1.18% | final price |
| XBI | the next day | -0.41% | final price |
| XBI | two days later | -3.64% | final price |
| XBI | three days later | -5.19% | still updating |
| XBI | three days earlier | -5.41% | final price |
| XBI | five days earlier | -1.25% | final price |
| XLV | that day | +0.27% | final price |
| XLV | the next day | +0.29% | final price |
| XLV | two days later | -0.10% | final price |
| XLV | three days later | -0.27% | still updating |
| XLV | three days earlier | -1.80% | final price |
| XLV | five days earlier | -2.31% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 21 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 67 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 34 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 41 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 67 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 81 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 47 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 83 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Mirum Pharmaceuticals (MIRM)
Companies tied to this story
- MIRM Mirum Pharmaceuticals
For “8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer),” Mirum Pharmaceuticals (MIRM) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> MIRM
How “8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)” reaches Mirum Pharmaceuticals (MIRM)
Mirum Pharmaceuticals (MIRM) is the company in “8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer),” the 10 Nov 2026 this story story.
The link for Mirum Pharmaceuticals (MIRM) is this: SEC 8-K filing -> direct issuer disclosure -> MIRM
How solid “8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)” looks
14 out of 100Price not final
“8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies. The price is not final yet.